MXPA04003594A - Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2. - Google Patents

Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2.

Info

Publication number
MXPA04003594A
MXPA04003594A MXPA04003594A MXPA04003594A MXPA04003594A MX PA04003594 A MXPA04003594 A MX PA04003594A MX PA04003594 A MXPA04003594 A MX PA04003594A MX PA04003594 A MXPA04003594 A MX PA04003594A MX PA04003594 A MXPA04003594 A MX PA04003594A
Authority
MX
Mexico
Prior art keywords
compounds
azaindoles
indolines
tetracyclic
serotonin
Prior art date
Application number
MXPA04003594A
Other languages
English (en)
Spanish (es)
Inventor
Fu Jian-Min
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MXPA04003594A publication Critical patent/MXPA04003594A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA04003594A 2001-10-18 2002-10-15 Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2. MXPA04003594A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33508101P 2001-10-18 2001-10-18
PCT/US2002/033176 WO2003033497A1 (en) 2001-10-18 2002-10-15 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity

Publications (1)

Publication Number Publication Date
MXPA04003594A true MXPA04003594A (es) 2004-07-30

Family

ID=23310182

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003594A MXPA04003594A (es) 2001-10-18 2002-10-15 Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2.

Country Status (7)

Country Link
US (1) US6930105B2 (enrdf_load_stackoverflow)
EP (1) EP1436294A1 (enrdf_load_stackoverflow)
JP (1) JP2005508969A (enrdf_load_stackoverflow)
BR (1) BR0213417A (enrdf_load_stackoverflow)
CA (1) CA2464412A1 (enrdf_load_stackoverflow)
MX (1) MXPA04003594A (enrdf_load_stackoverflow)
WO (1) WO2003033497A1 (enrdf_load_stackoverflow)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
US20050052815A1 (en) * 2003-09-09 2005-03-10 Smc Corporation Static eliminating method and apparatus therefor
EP2400300A1 (en) 2004-08-25 2011-12-28 Takeda Pharmaceutical Company Limited Method of screening preventives/remedies for stress urinary incontinence
GT200500317A (es) * 2004-11-05 2006-10-27 Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
WO2006117218A2 (en) * 2005-05-04 2006-11-09 Charite Universitätsmedizin - Berlin Serotonin-transport-protein binding radiopharmaceutical for the production of a diagnostic medicament for the diagnosis of headache
EP1728520A1 (de) * 2005-05-04 2006-12-06 Charité - Universitätsmedizin Berlin Verwendung von spezifisch an das Serotonin-Transport-Protein (SERT) bindenden Radiopharmaka zur Herstellung eines Diagnostikums zur Untersuchung von Kopfschmerzerkrankungen
AR054849A1 (es) * 2005-07-26 2007-07-18 Wyeth Corp Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
TW200734334A (en) * 2006-01-13 2007-09-16 Wyeth Corp Treatment of substance abuse
EP1998781A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Treatment of pain
JP2009531431A (ja) * 2006-03-24 2009-09-03 ワイス 認知障害および他の障害の治療方法
KR20080105104A (ko) * 2006-03-24 2008-12-03 와이어쓰 우울증 치료를 위한 신규한 치료학적 병용제
EP2742936A1 (en) 2006-05-16 2014-06-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
CL2008002777A1 (es) * 2007-09-21 2010-01-22 Wyeth Corp Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario.
EP2216023A4 (en) 2007-11-15 2013-03-13 Takeda Pharmaceutical CONDENSED PYRIDINE DERIVATIVE AND ITS USE
CA2743241A1 (en) * 2008-11-27 2010-06-03 Boehringer Ingelheim International Gmbh 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
US20120253036A1 (en) 2009-12-11 2012-10-04 Yukinori Nagakura Agent for treating fibromyalgia
JPWO2019131902A1 (ja) 2017-12-27 2020-12-10 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR023574A1 (es) * 1999-04-23 2002-09-04 Pharmacia & Upjohn Co Llc Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios
ATE277928T1 (de) 1999-06-15 2004-10-15 Bristol Myers Squibb Pharma Co Substituierte heterocyclylkondensierte gamma carboline

Also Published As

Publication number Publication date
CA2464412A1 (en) 2003-04-24
US6930105B2 (en) 2005-08-16
US20030091505A1 (en) 2003-05-15
WO2003033497A1 (en) 2003-04-24
EP1436294A1 (en) 2004-07-14
JP2005508969A (ja) 2005-04-07
BR0213417A (pt) 2004-11-03

Similar Documents

Publication Publication Date Title
MXPA04001203A (es) 1-h-pirido[4,3-b] indoles terapeuticos.
MXPA04003594A (es) Azaindoles e indolinas tetraciclicas que tienen actividad en serotonina 5-ht-2.
AP1822A (en) Substituted pyridinones as modulators of P38 MAP kinase.
TW200517109A (en) Substituted pyridinones
WO2001017963A3 (en) Aminoalkoxy carbazoles and their use as 5-ht ligands
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
MXPA02012425A (es) Compuestos nuevos.
SE0104140D0 (sv) Novel Compounds
MXPA05009359A (es) Tetrahidroisoquinolinas 2,5- y 2,6 substituidas para uso como moduladores 5-ht6.
GB9813540D0 (en) Chemical compounds
IL175819A0 (en) Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease
EP1633740A4 (en) CHEMICAL COMPOUNDS
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
WO2003024976A3 (en) Tricyclic indole derivatives as 5-ht ligands
ZA200110540B (en) Novel diphenyl-piperidine derivate.
TWI264437B (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
MXPA06000701A (es) Compuestos de sulfonildihidrobencimidazolona como ligandos de 5-hidroxitriptamina-6.
GB0104050D0 (en) Chemical compounds
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
UA83821C2 (ru) Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли
MXPA04000358A (es) Hexahidroazepino (4,5-g) indoles e indolinas como ligandos del receptor 5-ht.
MXPA04000036A (es) Benzofuranos sustituidos con (hetero) arilo como ligandos 5-ht.
SE9902551D0 (sv) Novel compounds
DE602004021363D1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen
MXPA02012426A (es) Compuestos nuevos.